TipRanks
XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB)
NASDAQ:XTLB
US Market
XTLB
XTL Biopharmaceuticals Sponsored ADR
RESEARCH TOOLSreports
Want to see XTLB full AI Analyst Report?

XTL Biopharmaceuticals Sponsored ADR (XTLB) Income Statement

146 Followers

XTL Biopharmaceuticals Sponsored ADR Income Statement

Last quarter (Q4 2024), XTL Biopharmaceuticals Sponsored ADR's total revenue was $289.00K, an increase of Infinity% from the same quarter last year. In Q4, XTL Biopharmaceuticals Sponsored ADR's net income was $-255.00K. See XTL Biopharmaceuticals Sponsored ADR’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 451.00K$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 3.00K$ 0.00$ -1.00K$ -1.00K
Operating Expenses
$ 1.69M$ 2.17M$ 765.00K$ 880.00K$ 1.03M
Depreciation and Amortization
$ 0.00$ 199.00K$ 1.00K$ 1.00K$ 1.00K
EBITDA
$ -752.00K$ -930.00K$ -764.00K$ -879.00K$ -1.03M
Operating Income
$ -1.69M$ -2.17M$ -765.00K$ -880.00K$ -1.03M
Other Income/Expenses
$ 929.00K$ 1.01M$ -1.02M$ -468.00K$ 1.47M
Pretax Income
$ -759.00K$ -1.16M$ -1.78M$ -1.35M$ 435.00K
Net Income
$ -6.97M$ -1.03M$ -1.78K$ -1.35M$ 435.00K
Per Share Metrics
Basic EPS
$ -17.00$ -2.40$ -30.00$ -4.00$ 1.28
Diluted EPS
$ -16.00$ -2.40$ -30.00$ -4.00$ 1.12
Weighted Average Shares Outstanding
 420.65K 420.65K 340.57K 340.57K 332.50K
Weighted Average Shares Outstanding (Diluted)
 440.10K 440.10K 340.57K 340.57K 384.72K
Currency in USD

XTL Biopharmaceuticals Sponsored ADR Earnings and Revenue History